ACVR1 and fibrodysplasia ossificans progressiva: An IC50 of 15 nM was determined using an in-cell immunofluorescent assay (Supplemental Figure 6), further confirming the ability of this molecule to block the neofunction of ALK2 implicated in the development of FOP.